Health Canada drug identification number

DIN 02239853 — ALLEGRA-D 60 MG; 120 MG

ALLEGRA-D is a tablet (immediate- and extended-release) of Fexofenadine / Pseudoephedrine marketed by SANOFI CONSUMER HEALTH INC. The full Fexofenadine / Pseudoephedrine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02239853
Brand name
ALLEGRA-D
Strength
60 MG; 120 MG
Dosage form
TABLET (IMMEDIATE- AND EXTENDED-RELEASE)
Route
ORAL
Manufacturer
SANOFI CONSUMER HEALTH INC
Health Canada status
MARKETED
Drug class
Histamine H1-receptor antagonist with sympathomimetic decongestant

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.